ArrowMark Colorado Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,110
Closed -$202K – 358
2021
Q1
$202K Sell
1,110
-449
-29% -$104K ﹤0.01% 340
2020
Q4
$312K Hold
1,559
– – ﹤0.01% 320
2020
Q3
$342K Hold
1,559
– – ﹤0.01% 313
2020
Q2
$298K Hold
1,559
– – ﹤0.01% 287
2020
Q1
$242K Sell
1,559
-16,281
-91% -$1.89M ﹤0.01% 293
2019
Q4
$1.49M Buy
17,840
+1,533
+9% +$117K 0.01% 258
2019
Q3
$1.1M Sell
16,307
-3,021
-16% -$199K 0.01% 243
2019
Q2
$1.28M Sell
19,328
-350
-2% -$20.4K 0.01% 264
2019
Q1
$1.09M Hold
19,678
– – 0.01% 272
2018
Q4
$975K Hold
19,678
– – 0.01% 292
2018
Q3
$1.7M Hold
19,678
– – 0.01% 287
2018
Q2
$1.14M Buy
+19,678
New +$961K 0.01% 290

Other funds holding TDOC

ArrowMark Colorado Holdings's TDOC Position: Q2 2021 in Review

ArrowMark Colorado Holdings sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 1,110 shares — an estimated $202K sold.

ArrowMark Colorado Holdings first reported a position in TDOC in Q2 2018 and held it in 12 quarters. The position peaked at $1.7M in Q3 2018. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • ArrowMark Colorado Holdings reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 1,110 Teladoc Health shares in Q2 2021, an estimated $202K.
  • ArrowMark Colorado Holdings first reported a position in Teladoc Health in Q2 2018 and held it in 12 quarters.
  • ArrowMark Colorado Holdings's Teladoc Health position peaked at $1.7M in Q3 2018.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.